✅ Product Benefits & Highlights

• Dual-action therapy: Empa 25 mg Tablet contains Empagliflozin, an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys, lowering blood sugar levels and reducing cardiovascular risk in patients with type 2 diabetes .

• Recommended dosage: The initial dose is 10 mg once daily, which may be increased to 25 mg once daily in patients tolerating the medication .

• Affordable pricing: Available at approximately ৳50 per tablet, with a box of 10 tablets priced around ৳500, making it an economical choice for patients in Bangladesh .

• Manufacturer: Produced by NIPRO JMI Pharma Ltd., a reputable pharmaceutical company in Bangladesh